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Macrophages express both CXCR4 and CCR5 coreceptors, but restrict X4 HIV-1 replication unless the Env-V3 region, a
major determinant of cell tropism, is exchanged with that of R5 HIV-1. As the V3 exchange concomitantly alters the nucleotide
sequences, we introduced silent mutations in the V3 or C2 region of macrophage-tropic R5 JRFL without changing the amino
acids. Immunoblot analysis confirmed that viral proteins including Env-gp120 were similarly incorporated in wild-type (wt) and
mutant virions. The silent mutants infected CCR5-positive MAGIC5 cells but not CCR5-negative MAGI cells, as productively
as wt viruses, indicating that the silent mutations did not alter coreceptor utilization. In contrast, two of three silent V3-mutant
viruses failed to replicate efficiently in primary macrophages, whereas other V3- or C2-mutants and wt JRFL infected
macrophages productively. Furthermore, synthesis of the full-length viral DNA of the aberant V3-mutant was largely reduced
in macrophages. These results suggest that V3 nucleotide sequences may be one of the postentry factors restricting HIV-1
replication in macrophages. © 2002 Elsevier Science (USA)INTRODUCTION
Human immunodeficiency virus type 1 (HIV-1) is char-
acterized by its genetic diversity, which results in differ-
ences in virus phenotypes such as preferential infection
of target cells, efficiency of replication, and syncytium-
inducing ability. Although almost all HIV-1 isolates pro-
ductively infect macrophages and CD4 T lymphocytes,
most HIV-1 strains show specificity for macrophages or
culture-adapted T cell lines. This diversity, known as cell
tropism of HIV-1, macrophage tropism (M-tropism), and
T-cell tropism (T-tropism), correlates with the pathogen-
esis and clinical course of infection (Bandres and Martin,
1999; Berger et al., 1999; Freed and Martin, 2001). Since
macrophages serve as an HIV-1 reservoir, and T-lympho-
cytes work as a high producer of HIV-1, a number of
studies have been carried out for characterization of
factors involved in the HIV-1 tropism.
Immediately after the discovery of the CCR5 and
CXCR4 coreceptors as cellular factors for HIV-1 infection,
virus isolates were classified into two major groups ac-
cording to coreceptor usage: CCR5-utilizing virus (R5
virus) and CXCR4-utilizing virus (X4 virus) (for review, see
Bandres and Martin, 1999). As the majority of M-tropic
and T-tropic viruses preferentially use CCR5 and CXCR4© 2002 Elsevier Science (USA)
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192as coreceptor to enter target cells, respectively, cell tro-
pism of HIV-1 has been implicated by coreceptor utiliza-
tion (Alkhatib et al., 1996; Bluel et al., 1996; Choe et al.,
1996; Dragic et al., 1996; Feng et al., 1996; Oberlin et al.,
1996). As to viral factors involved in HIV-1 entry, a specific
region of the Env gp120 protein, the V3 loop, was dem-
onstrated to be a major determinant of coreceptor usage
(Bieniasz et al., 1997; Cocchi et al., 1996; Hoffman et al.,
1998; Hung et al., 1999a; Trkola et al., 1996; Wu et al.,
1996) as well as cell tropism (O’Brien et al., 1990; Shioda
et al., 1991; Trujillo et al., 1996; Westrvelt et al., 1992). X4
viruses, in which only the V3 loop was replaced with that
of R5 viruses, changed their coreceptor utilization to
CCR5 and replicated efficiently in macrophages, while
R5 viruses containing the V3 loop of X4 viruses utilized
CXCR4 and replicated poorly in macrophages (Chesebro
et al., 1992, 1996; Speck et al., 1997). However, there still
remains a puzzling question about M-tropism.
Macrophages are known to express sufficient levels of
the CD4 receptor and CCR5 and CXCR4 coreceptors
(Lee et al., 1999). However, not all X4 viruses can pro-
ductively infect macrophages, whereas most R5 viruses
can. This macrophage restriction is highly controversial,
with several articles supporting the restriction at the viral
entry step, and others supporting it at the postentry step.
Entry defects have been explained by structural changesKey Words: HIV-1; macrophages; cell tropism; envelope
coreceptor usage; R5 virus.
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in the Env protein due to viral genetic mutations that
cause reduced fusion capacity, by low CD4 and/or; V3 re
CXCR4 densities on macrophages that are insufficient
for membrane fusion, and by reduced interaction affini-
ties between Env and CD4 and/or CXCR4 that are unable
to promote the fusion process (Lapham et al., 1999;
Simmons et al., 1998; Tokunaga et al., 2001; Verani et al.,
1998; Yi et al., 1998, 1999).
As to the postentry restriction, previous studies de-
scribed that both R5 and X4 viruses could enter macro-
phages, but X4 viruses poorly replicated possibly due
to the defect in the nuclear transport of viral DNA
(Schimidtmayerova et al., 1998). Furthermore, efficient
replication of R5 viruses in macrophages was implicated
by signal transduction via interaction of CCR5 and Env
(Arthos et al., 2000), although the role of the V3 loop at
postentry levels is not fully understood. Recently, the
replacement of the V3 loop of X4 viruses with that of R5
viruses was shown to be insufficient for their replication
in macrophages (Dittmar et al., 1997; Hung et al., 1999b;
Kato et al., 2000), suggesting the involvement of other
viral and/or cellular factors. Exchange of the V3 loop
between X4 and R5 viruses may transfer the ability of Env
to interact with coreceptors, and concomitantly transfer
the V3-coding nucleotide sequences that may possibly
influence the viral replication steps after entry into target
cells.
To study the effect of mutations in nucleotide se-
quences in the V3 region without alteration of the amino
acid sequences, we have constructed silent mutants of
M-tropic JRFL by introducing synonymous substitutions
at the third base of codons in the V3 region and inves-
tigated the ability of these mutant viruses to replicate in
CCR5-expressing CD4-HeLa cells, and primary macro-
phages and lymphocytes. Our results demonstrate that
certain V3-mutants, which retain the ability to use CCR5,
lose the ability to replicate efficiently in macrophages,
and that the major block is at the step of reverse tran-
scription. These results suggest that nucleotide se-
quences in the V3 region may be one of the factors
restricting HIV-1 replication in macrophages.
RESULTS
Mutant JRFL viruses with synonymous substitutions in
the V3 or C2 region
The V3 region of Env gp120 was considered to be
critical for the cell tropism of HIV-1 infection. M-tropic
virus mutants whose V3 region was replaced with that of
the T-tropic virus lost their infectivity to macrophages,
while T-tropic virus mutants with the M-tropic V3 region
gained it (Chesebro et al., 1992, 1996; Speck et al., 1997).
However, the replacement of the V3 region results in the
alteration of not only amino acid (aa) sequences but also
nucleotide sequences. To study the effects of the altered
V3 nucleotide sequences without consequent aa se-
quence changes on cell tropism, we constructed several
JRFL proviral clones with silent mutations in the V3 or C2
region (Fig. 1). Synonymous substitutions were intro-
duced in portions of the V3 region that were different in
nucleotide sequences between JRFL and NL432 clones,
which are represented by shaded bars in Fig. 1. Amino
acids from positions 1 to 3 were silently mutated for Jm1,
Jm2, and Jm3. Furthermore, Jm1, Jm2, and Jm3 were
silently mutated in the distal part (positions 17 to 21), the
proximal part (positions 12 to 16), and in both parts from
the GPGRAF tip, respectively. The C2 region is highly
conserved among HIV-1 strains, and a portion where
JRFL and NL432 have the same nucleotide sequence
was selected and silently mutated in five continuous
codons for JC2m as a control (Fig. 1). Therefore, mutant
Jm1, Jm2, Jm3, and JC2m viruses have different nucleo-
tide sequences in the V3 or C2 region from that of wt
JRFL, but encode the same aa sequences as that of the
wt JRFL virus.
Effects of silent mutations on incorporation of viral
proteins into virions
Viral proteins of silent mutants constructed as de-
scribed above were examined by Western blot analysis.
293T cells were transfected with wild-type (wt) and mu-
tant provirus DNAs, and virions were collected from the
culture supernatants by ultracentrifugation. Protein con-
tents of virion lysates were adjusted by p24 antigen
ELISA and viral proteins were analyzed by immunoblot-
ting using highly Env-reactive anti-HIV-1 serum (Fig. 2A)
and the sera from HIV-1 patients (Fig. 2B). The expres-
sion patterns and levels of viral proteins including Env,
Gag, and Pol proteins in mutant Jm1, Jm2, Jm3, and JC2m
virions were similar to those in wt virions. This result
indicates that the introduction of silent mutations into the
V3 or C2 region of the env gene does not affect the
incorporation and composition of viral proteins in virus
particles.
Ability of silent mutants to replicate in primary
macrophages, lymphocytes, and coreceptor-
expressing HeLa cell lines
As the V3 region is known to be a major determinant
of coreceptor usage, the replication of silent V3-mutants
was examined in CD4- and CXCR4-positive HeLa-CD4-
LTR--gal (MAGI) cells and in MAGIC5 cells which were
generated from MAGI cells by transfection with a CCR5-
expression plasmid, and were susceptible to infection by
R5 viruses (Hachiya et al., 2001). The cells were infected
with wt or V3-mutant JRFL viruses, and the expression
levels of the p24 antigen in culture supernatants were
determined 2, 3, and 4 days after infection. Figure 3A
clearly shows that no detectable amounts of p24 antigen
were produced in CCR5-negative MAGI cells infected
with wt and V3-mutant JRFL viruses. On the other hand,
when CCR5-positive MAGIC5 cells were infected with wt
and V3-mutant viruses, substantial amounts of p24 anti-
193HIV RESTRICTION BY V3 NUCLEOTIDE SEQUENCE
gen were detected on day 2 and increased on days 3 and
4, although the amounts of p24 antigen were slightly
smaller in Jm2 and Jm3 mutants than in wt and Jm1. The
results of five experiments were consistent and a repre-
sentative result is shown in Fig. 3B. These results sug-
gest that silent V3-mutants of the JRFL virus utilize CCR5
as a coreceptor for infection and replicate in permissive
cells as efficiently as the wt JRFL virus does.
Since JRFL is an M-tropic R5 virus, we examined the
replication of mutant JRFL viruses in primary macro-
phages and PBLs. PBMCs were fractionated into adher-
ent and nonadherent cells for macrophage and lympho-
cyte cultures, respectively. Adherent cells differentiated
in the presence of M-CSF for 7 days were used as
primary macrophages. Nonadherent cells were stimu-
lated with PHA for 3 days and then with rIL-2 overnight
and used as primary PBLs. Figure 3C shows a represen-
tative result of four reproducible experiments on macro-
phage infection. Since NL432 is known to be a T-tropic
X4 virus and is unable to replicate efficiently in macro-
phages, the amounts of p24 antigen in the culture su-
pernatants were very low. In contrast, the wt JRFL virus
replicated efficiently and produced increasing amounts
of p24 antigen from 6 to 9 days. A silent V3-mutant, Jm1,
showed replicability in macrophages similar to that of wt
JRFL. However, other silent V3-mutants, Jm2 and Jm3,
produced markedly lower amounts of p24 antigen than
FIG. 1. Nucleotide sequences of silent JRFL mutant clones. Mutations were introduced, such that the amino acid sequence is preserved, into the
third base of codons in the V3 and C2 regions of the JRFL clone, which are represented schematically at the top of the figure. Thus, silently mutated
viruses, Jm1, Jm2, Jm3, and JC2m, possessed different nucleotide sequences but possessed the same amino acid sequence as that of wild-type JRFL.
Mutated nucleotides, codons, and corresponding amino acids are shown in bold letters. The nucleotide and amino acid sequences of the NL432 V3
and C2 regions are also shown for reference. Shaded bars indicate different portions between JRFL and NL432.
FIG. 2. Western blot analysis of wild-type and mutant virions of JRFL
strain. Culture supernatants of 293T cells transfected with a plasmid
vector (mock), or an infectious DNA clone of wild-type or silent mutants
(Jm1, Jm2, Jm3, and JC2m) were ultracentrifuged at 100,000 g for 60 min.
Precipitated virions were lysed with the SDS–PAGE sample buffer and
analyzed by immunoblotting with the anti-HIV-1 strong positive control
R-1 serum (Bio-Rad) (A) and HIV-1-infected patient sera (B). Arrow-
heads indicate viral proteins: gp120, envelope; p55, Gag precursor; p31,
endonuclease; p24, capsid; and p17, matrix proteins.
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wt JRFL and Jm1 did. Another mutant virus, JC2m, that
had similar silent substitutions in the conserved C2 re-
gion of JRFL, replicated in macrophages as efficiently as
the wt JRFL virus in contrast to the V3-mutant Jm2 virus
(Fig. 3D). The amounts of p24 antigen in macrophage
cultures infected with wt JRFL and C2-mutant JC2m vi-
ruses increased on days 6 and 9, whereas those infected
with the Jm2 virus were low even 9 days after infection.
Furthermore, primary human PBLs were infected with the
Jm2 virus as a representative of V3-mutants to examine
whether the effects of the silent mutations also occur
with other primary cell types. As shown in Fig. 3E, V3-
mutant Jm2 replicated productively in primary PBLs. Jm2
produced increasing amounts of p24 antigen on day 5
with a peak 7 days after infection as wt JRFL virus did.
These results indicate that the replication of silent V3-
mutants, such as Jm2, was severely restricted in primary
macrophages.
Ability of silent V3-mutants to induce syncytium
formation
Because the amounts of p24 antigen do not necessar-
ily correlate with phenotypes of infection, we examined
the infectivity of silent V3-mutants using the blue focus
(MAGI) assay (Kimpton and Emerman, 1992). MAGIC5
cells were infected with equal amounts of p24 from wt
and mutant JRFL viruses. Two days later, infected cells
were fixed and stained with X-Gal. As shown in Fig. 4, the
number of blue foci caused by cell fusion did not differ
among cells infected with all the viruses (Fig. 4F), and
syncytia were formed to similar degrees (Figs. 4B–4E).
Therefore, Jm1, Jm2, and Jm3 V3-mutant viruses pos-
sessed the same phenotype of infection to CCR5-posi-
tive MAGIC5 cells as the wt JRFL virus did. When the
infectious focus assay was carried out using CCR5-
negative MAGI cells, no blue focus was detected (data
not shown).
The wt JRFL virus induces syncytium formation in mac-
rophages after prolonged infection. Therefore, macro-
phages infected with wt and V3-mutant JRFL viruses
were cultured up to 18 days after infection to assess
whether mutant viruses retained the phenotype of the
parental wt virus. Figure 5 shows Wright–Giemsa-
stained infected macrophages. The wt JRFL virus, but not
the T-tropic NL432 virus, induced syncytium formation as
reported previously (Chesebro et al., 1992). A silent mu-
tant, Jm1, induced syncytium formation in macrophages
as wt JRFL did (Fig. 5D). In contrast, few syncytia, if any,
FIG. 3. Replication of wild-type and mutant JRFL viruses in Hela-CD4 cell lines and primary human blood cells. CD4- and CXCR4-positive MAGI
cells (A) and MAGI-derived, CCR5-expressing MAGIC5 cells (B) (105 cells) were infected with an equal amount of p24 antigen (10 ng) of wild-type or
silent-mutant viruses (Jm1, Jm2, and Jm3) of the JRFL strain. Culture supernatants were obtained on days 2, 3, and 4. Adherent macrophages (C and
D) and nonadherent lymphocytes (E) were prepared from PBMCs as described under Materials and Methods. Differentiated macrophages and
lymphocytes were infected with an equal amount of p24 (15 ng for macrophages and 20 ng for lymphocytes) of either T-tropic NL432, M-tropic JRFL,
or mutant JRFL (Jm1, Jm2, Jm3, and JC2m) viruses. Culture supernatants were obtained on the indicated days after infection. The amounts of virion
in the culture supernatants were determined by p24 Ag ELISA. When cells were cultured in triplicate, results were expressed as the means  SD.
, mock infection; E, wt JRFL; ‚, Jm1; F, Jm2; Œ, Jm3; , JC2m; , wt NL432.
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were observed in macrophages infected with silent mu-
tants, Jm2 and Jm3 (Figs. 5E and 5F, respectively). These
results also suggest that the introduction of silent muta-
tions in the V3 region of M-tropic R5 JRFL may decrease
the abilities of the viruses to replicate efficiently and to
induce syncytium formation in macrophages without af-
fecting coreceptor usage.
Reverse transcription of silent V3-mutants in primary
macrophages
The synthesis of HIV-1-specific DNA was examined in
macrophages infected with T-tropic NL432, M-tropic
JRFL, and V3-mutant Jm2 viruses to search the defective
step of viral replication. First, strong stop DNA was ex-
FIG. 4. Infectivity of wild-type and mutant viruses in MAGIC5 cells. MAGIC5 cells (105 cells) were mock-infected (A), or infected with wild-type (B),
silent-mutant Jm1 (C), Jm2 (D), or Jm3 (E) viruses. Two days after infection, cells were fixed with 1% formaldehyde–0.2% glutaraldehyde and stained
with X-Gal. The number of blue foci (F) was determined automatically and expressed as the mean of triplicate cultures  SD.
FIG. 5. Syncytium formation of differentiated macrophages infected with silent mutants of JRFL viruses. Adherent cells in 12-well plates were
cultured for 7 days with M-CSF (2 ng/ml). Differentiated macrophages were then mock-infected (A), or infected with an amount of p24 (15 ng) of T-tropic
NL432 (B), M-tropic JRFL (C), or mutant JRFL viruses [Jm1 (D), Jm2 (E), and Jm3 (F)]. Cells were fed every 3 days and fixed 18 days after infection. Cells
were visualized by Wright–Giemsa staining.
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amined with R/U5 primers, which is the early product of
reverse transcription shortly after viral entry and after-
wards represents all families of viral DNA. As shown in
Fig. 6B, infection with the wt JRFL and mutant Jm2 viruses
gave similar results; a positive PCR band was observed
as early as 2 h after infection, and it was also detected at
similar intensities 24 and 48 h later for JRFL and Jm2.
However, the strong stop DNA band of NL432 was
weaker than that of JRFL or Jm2 at 2 h and was unde-
tectable 24 and 48 h after infection. When the full-length
viral DNA was examined using LTR/Gag primers, the
difference in reverse transcription was observed be-
tween wt JRFL and V3-mutant Jm2. The full-length DNA of
JRFL was clearly detected and increased at 48 h in
infected macrophages, whereas that of Jm2 and NL432
was slightly detectable 48 h after infection (Fig. 6C).
Circular forms of the full-length DNA are produced after
entry into the nucleus and detected by two LTR primers.
Figure 6D shows that the intranuclear HIV-1 DNA circles
were positive only in JRFL-infected macrophages at 48 h.
No DNA circle was detectable by two LTR primers in
macrophages infected with Jm2 and NL432. These re-
sults indicate that the inability of V3-mutant Jm2 to rep-
licate efficiently in macrophages correlates with reduced
levels of reverse transcription.
Computer analysis of secondary RNA structures of
the V3 region
Thermodynamically stable stem-loop structures are
proposed to be scattered throughout the HIV-1 RNA
genome and are suggested to affect viral transcription
and/or replication (Freed and Martin, 2001). To address a
possibility that the V3 region of the JRFL or V3-mutant
viruses may possess one such an easily or hardly rep-
licable RNA structure, their V3 nucleotide sequences
were predicted in computer models of minimum free
energy to form a secondary RNA structure. The com-
puter-assisted structure prediction is shown in Fig. 7.
V3-RNA of T-tropic NL432 and M-tropic JRFL was theo-
retically able to form thermostable (22.31 kcal/mol) and
destabilized (17.17 kcal/mol) conformations, with eight
and five stem-loop structures, respectively. The replica-
tion-defective Jm3 V3-mutant was calculated to have a
thermostable V3-RNA structure with minimum free en-
ergy of 22.11 kcal/mol and morphology similar to those
of NL432. On the other hand, the V3-RNA folding models
of defective Jm2 and replicable Jm1 resembled each
other in shape, but not that of V3-mutant Jm3 or JRFL. In
addition, the calculated thermostability of Jm2 V3-RNA
was a stable level of free energy (21.81 kcal/mol), but
that of Jm1 was an intermediate level (19.81 kcal/mol).
These results suggest that a more complex defect(s)
than tightly folding of V3-RNA structures may be involved
in the reduced levels of reverse transcription for the
V3-mutants.
DISCUSSION
In this study, we constructed silently mutated viruses
of the M-tropic R5 JRFL strain which carry synonymous
substitutions in the V3 region of the env gene and sug-
gest that nucleotide sequences in the V3 region play an
important role in efficient virus replication in primary
macrophages.
The V3 loop of Env protein has been demonstrated to
be important in HIV-1 entry into target cells using chi-
meric viruses in which the V3 loop was replaced with
that of either R5 or X4 viruses (Chesebro et al., 1992,
1996; Speck et al., 1997). As most M-tropic and T-tropic
viruses preferentially use CCR5 and CXCR4 coreceptors
for viral entry, respectively, cell tropism of HIV-1 was
accounted for its coreceptor utilization. Thus, the ability
of Env to use a coreceptor at the fusion process between
the cellular and viral membranes is the first major re-
striction point in cell tropism of HIV-1 infection. In agree-
FIG. 6. Reverse transcription of the HIV-1 genomes in macrophages. Differentiated macrophages were infected with T-tropic NL432, M-tropic wt
JRFL, and mutant Jm2 viruses. Cell lysates were prepared 2, 24, and 48 h after infection. Each lysate diluted 1:10 was subjected to PCR amplification
using primers from the LTR R/U5 region (strong stop DNA) (B), LTR/Gag region (full-length DNA) (C), and 2 LTR circles (intranuclear DNA) (D). A primer
pair from the -tublin gene (A) was used as a cellular control. Panels on the left show different dilutions of the cell lysates prepared 2 h after JRFL
infection as sensitivity controls.
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ment with this conclusion, our silent mutants efficiently
replicated and formed syncytium in CCR5-expressing
MAGIC5 cells but not in CCR5-negative MAGI cells as
the parental M-tropic R5 JRFL virus did, because they
have the same aa sequence in the V3 loop, and hence,
probably the same interacting conformation of Env to
CCR5 as that of the wt JRFL virus.
On the other hand, it is pointed out that coreceptor
usage is not necessarily correlated with cell tropism of
HIV-1 (Dittmar et al., 1997). Indeed, several reports have
recently described X4 HIV-1 isolates which replicated in
macrophages (Simmons et al., 1998), R5 isolates, and
V3-mutant R5 or dual X4/R5 clones which did not pro-
ductively infect macrophages (Arthos et al., 2000; Hung
et al., 1999b; Kato et al., 2000). Furthermore, the T-tropic
molecular clone Mac239 of SIV utilized CCR5 to enter
macrophages, but failed to complete viral replication
(Mori et al., 1993). Our results presented here also con-
firm the discrepancy between coreceptor utilization and
cellular tropism. M-tropic JRFL and its V3-mutants, Jm1,
Jm2, and Jm3, all used CCR5 for viral entry. However, only
JRFL and Jm1 infected macrophages efficiently, whereas
Jm2 and Jm3 replicated in macrophages at low levels.
The nonproductive infection of the silent V3-mutant was
observed when primary macrophages were used as
target cells, but not when primary lymphocytes were
used as another cell type susceptible to infection by both
M-tropic and T-tropic isolates. This phenotype of infec-
tion of the aberrant V3-mutant may reflect that of natu-
rally occurring HIV-1 mutants in vivo, since the majority of
primary isolates infect CD4 lymphocytes, but only a
subset of them are capable of replicating in macro-
phages (Arthos et al., 2000; Dittmar et al., 1997). Our
search for V3 sequences of primary isolates is in favor of
the hypothesis on phenotypes of real isolates. No iso-
lates with nucleotide sequences similar to our V3-mu-
tants were found in databases. Once similar silent mu-
tations occurred, such viruses might lose their infectivity
to reservoir macrophages and might consequently fade
out during the course of infection.
Macrophages are known to express substantial levels
of both CXCR4 and CCR5 coreceptors on the cell surface.
It is puzzling why macrophages do not allow efficient
replication of T-tropic X4 viruses but allow that of M-
tropic R5 viruses. The M-tropism or macrophage restric-
tion is a highly controversial issue. There have been
FIG. 7. The predicted secondary RNA structures and minimum free energy of the V3 region. Computer analysis was performed with GENETYX-MAC
software. Minimum free energy (in kilocalories per mole) calculated is also shown in parentheses. The sequences with silent mutations are marked
by open boxes. The corresponding sequences of wt JRFL and NL432 are marked by gray boxes.
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many reports supporting HIV-1 entry restriction in mac-
rophages, which suggest the influences of aa changes in
the Env protein, CD4, and CXCR4 densities on the cell
surface of target macrophages, and interaction affinities
among Env, CD4, and CXCR4 molecules (Lapham et al.,
1999; Simmons et al., 1998; Tokunaga et al., 2001; Verani
et al., 1998; Yi et al., 1998, 1999). On the contrary, several
reports support postentry restriction. Recently, Arthos et
al. (2000) reported that an R5 isolate, 92MW959, which
entered macrophages but failed to replicate, was capa-
ble of overcoming the restriction when macrophages
were infected under stimulation with MIP-1. The study
suggests that signal transduction through the interaction
between the viral envelope and CCR5 provides a stimu-
lus which promotes viral replication in macrophages.
JRFL used in our study as a parental virus, which is
M-tropic, utilizes CCR5 and possesses different aa and
nucleotide sequences from those of 92MW959 mainly in
our mutated portions of the V3 loop, has been shown to
sufficiently induce envelope-CCR5 signal transduction
(Arthos et al., 2000). Therefore, the envelope-mediated
stimulus is likely to occur equally in macrophages with
our silent V3-mutants because their aa sequences and
Env incorporation into virions are similar to those of JRFL.
Nevertheless, the levels of replication of V3-mutants ex-
cept for Jm1 were low in macrophages. The difference
between the highly and poorly replicable viruses is only
in the mutated nucleotide sequences of the V3 loop.
Our PCR results of HIV-1 DNA also suggest that the
failure of V3-mutants to replicate efficiently in macro-
phages is due to a postentry defect, mainly at the step of
reverse transcription. The finding that the levels of full-
length viral DNA of the replication-deficient V3-mutant
were largely reduced, although those of early DNA prod-
ucts of reverse transcription were as high as that of wt
JRFL, is markedly consistent with the results of the PCR
study reported by Eisert et al. (2001). They also described
that restricted R5 HIV-1 infection of macrophages de-
rived from different donors was reflected by the reduced
full-length HIV-1 DNA formation in spite of the significant
synthesis of early DNA transcripts without donor differ-
ences. Their results suggest the involvement of host
genetic factors, whereas ours suggest that of nucleotide
sequence factors in the virus genome, and both suggest
no defects in viral entry. The silent mutations introduced
in the hypervariable parts of V3 altered the efficiency of
reverse transcription. The mutations are located in parts
distal and proximal to the relatively conserved GPGRAF
tip for replication-competent Jm1 and -incompetent Jm2,
respectively, and in both parts for replication-incompe-
tent Jm3. Therefore, the nucleotide sequence of the prox-
imal part seems to be important for efficient reverse
transcription of the viral RNA genome in macrophages,
although the underlying mechanisms of this part in af-
fecting reverse transcription are as yet unclarified.
Species of RNA such as tRNAs and mRNAs are known
to form partly thermostable stem-loop structures. The
HIV-1 genome is classified as an mRNA type and is
presumed to contain highly stable secondary structures
in the entire genome which influence viral replication, for
example, the TAR element in LTR, the principal RNA
packaging signal upstream of the gag gene, the RRE
structure in the env gene, and multiple inhibitory se-
quences associated with the instability of HIV-1 mRNA
throughout the gag, pol, and env genes (Freed and Mar-
tin, 2001). Therefore, it may be possible that one of the
critical motifs for efficient reverse transcription which are
scattered in the RNA genome is located in the V3 region,
and that RNA structural effects of V3 nucleotide changes
are responsible for the defect of the V3-mutants in the
reverse transcription process. Productive macrophage
infection of our JC2m virus that contains similar silent
mutations in the highly conserved C2 region may be
implicated in the absence of the hypothetical motif in the
mutated part. In fact, our computer analysis of secondary
V3-RNA structures and their thermodynamic stability pre-
dicted tightly and loosely folded RNA conformations, with
eight and five stem-loops, for T-tropic NL432 and M-
tropic JRFL, respectively. If silently mutated V3-RNA se-
quences were folded into thermostable stem-loop struc-
tures, larger energy will be required to unfold the tight
RNA structures for efficient reverse transcription. In favor
with this hypothesis, the replication-defective Jm2 and
Jm3 mutants were calculated to have tightly folded V3-
RNA secondary structures as NL432 was. However, V3-
mutant Jm1 that replicated similar to wt JRFL in macro-
phages scored an intermediate thermostability between
JRFL and NL432. Furthermore, representative M-tropic
HIV-1 strains, BAL and ADA, were predicted to form
tightly and loosely folded V3-RNA secondary structures,
respectively. These secondary RNA structures and ther-
mostability are calculated merely for possible intramo-
lecular base-pairing of the V3 nucleotide sequences in
the single RNA strand. However, HIV-1 possesses two
copies of the RNA genome. Therefore it may be too
simplistic to suggest that the single RNA strand of the V3
region has one static conformation. Several factors other
than reverse transcriptase and integrase have been re-
ported to associate with two copies of the HIV-1 RNA
genome in replication complexes such as the MA and
NC Gag proteins, the Vpr accessory protein, and cellular
cyclophilin A (Freed and Martin, 2001), and it seems
possible that the conformation made by the dimerized
RNA may change during consecutive processes of re-
verse transcription under influences of these or other
unknown factors.
Alternatively, primary RNA sequence effects rather
than RNA structural effects might contribute to the rep-
lication defects of the silent V3-mutants during reverse
transcription reactions in macrophages. Notably, HIV-1
genomic RNA contains a significantly higher adenine (A)
ribonucleotide content than mammalian genomes (Berk-
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hout and Hermert, 1994; Kypr et al., 1989). In addition,
based on the A-rich bias, codon usage in HIV-1 has been
reported to be atypical, strikingly favoring A-containing
and A-rich codons where A is located especially at silent
positions (Grantham and Perrin, 1986; Kypr and Mrazek,
1987; Sharp, 1986). As (AT)-rich segments of mamma-
lian genomes are known to replicate in late phases of the
cell cycle, the A-pressure of the HIV-1 genome may
possibly affect the efficiency of reverse transcription of
our silent mutants. In fact, the env gene of M-tropic JRFL
preferentially utilizes A-rich codons in 11 of 12 aas that
have different numbers of A in their triplets; the only
exception is Gln that utilizes 18 CAA but 21 CAG codons.
In this study, a total of 6, 4 and 8 As of 9 As located at the
silent third-base position were changed to non-A nucle-
otides for Jm1, Jm2, and Jm3, respectively. This finding
suggests that A-richness is not necessarily correlated
with replication efficiency in macrophages. The manipu-
lated parts of V3 only form a marginal field in the entire
env gene, and A-composition only differs slightly among
wt JRFL and its V3-mutants. Furthermore, our scanning of
databases demonstrated that the frequencies of A-rich
codon usage were not different between each of the five
representative M-tropic R5 and T-tropic X4 HIV-1 clones.
Taken together, the A-rich nature of the primary HIV-1
RNA sequence may not be implicated in the reverse
transcription defect of the V3-mutants.
Although it is still unknown how viral replication is
restricted in macrophages, we present here a possibility
that nucleotide sequences in the V3 region in M-tropic
viruses is another restriction factor which permits en-
hanced viral replication. This study may provide a key
suggestion to solving the puzzling question about cell
tropism of HIV infection.
MATERIALS AND METHODS
Construction of mutant HIV-1 clones
An infectious proviral DNA clone, pUC19/JRFL (Koya-
nagi et al., 1987), was digested with StuI and MunI. The
0.8-kb StuI-to-MunI fragment containing the C2 and V3
regions was inserted into the StuI and MunI sites which
had been constructed in pBluescriptSK(). The recom-
binant pBluescriptSK() containing the C2 and V3 re-
gions of JRFL was used as a template and subjected to
the Kunkel mutagenesis (Kunkel et al., 1987). Mutagenic
oligonucleotides were designed to introduce mutations
at the desired sites. The sequences of the oligonucleo-
tides used were as follows: for Jm1, 5-C TGG TCC GAT
GTG GAT ACT TT-3 and 5-GC TTG TCT GAT GTC ACC
GAT GAT TTC TCC-3; for Jm2, 5-C TGG TCC GAT GTG
GAT ACT TT-3 and 5-CC TAT CTC ACC AGT TGT GTA
AAA TGC-3; for Jm3, 5-C TGG TCC GAT GTG GAT ACT
TT-3 and 5-GC TTG TCT GAT GTC ACC GAT GAT CTC
ACC AGT TGT GTA AAA TGC-3; for JC2m, 5-CCA ATT
CCC ATC CAC TAC TGC GCT CCG GCT GG-3. Site-
directed mutagenesis was performed using an in vitro
mutagenesis kit according to the manufacturer’s protocol
(Bio-Rad, Richmond, CA). Silent mutations introduced
into the V3 or C2 region were confirmed by sequencing
of the pBluescriptSK()/Jm1, /Jm2, /Jm3, and /JC2m plas-
mids isolated. The 0.8-kb StuI-to-MunI mutated fragment
from each plasmid was replaced with the corresponding
fragment of the parental pUC19/JRFL clone to construct
the infectious provirus pUC19/Jm1, /Jm2, /Jm3, and /JC2m
clones which contain silent mutations in the V3 or C2
region (Fig. 1).
Cell lines
HeLa-CD4-LTR--Gal (MAGI) cells (Kimpton and Emer-
man, 1992) were obtained through the AIDS Research
and Reference Reagent Program of the National Insti-
tutes of Health. Stable MAGIC5 cells, which were a kind
gift from M. Tatsumi, were established from MAGI cells
by transfection with an expression vector for CCR5, and
therefore, were susceptible to infection by both M-tropic
and T-tropic viruses (Hachiya et al., 2001). MAGI,
MAGIC5, and 293T cells were maintained in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with
10% heat-inactivated fetal bovine serum (FBS). Cells
were cultured at 37°C in a humidified atmosphere con-
taining 5% CO2.
Isolation of human macrophages and lymphocytes
Peripheral blood mononuclear cells (PBMCs) from
healthy donors were separated on a Ficoll–Hypaque
(Amersham Pharmacia Biotech AB, Uppsala, Sweden)
gradient. PBMCs were plated at a density of 106 cells/
cm2 and allowed to adhere to a plastic dish for 1 h at
37°C in the RPMI1640 medium supplemented with 10%
heat-inactivated human serum (HS). The cells were then
divided into nonadherent and adherent cells for lympho-
cyte and macrophage cultures, respectively. Nonadher-
ent cells were suspended in PRMI1640 supplemented
with 10% heat-inactivated FBS and cultured for 3 days in
the presence of 5 g/ml phytohemagglutinin (PHA-P:
Sigma Chemical Co., St. Louis, MO). Suspended cells
were recovered from the PHA-stimulated cultures and
used as peripheral blood lymphocytes (PBLs). For mac-
rophage cultures, adherent cells were allowed to differ-
entiate for 7 days in the presence of 10% HS and 2 ng/ml
recombinant human macrophage colony-stimulating fac-
tor (M-CSF: Sigma). The differentiated macrophages
were maintained in the same medium. The medium was
replaced with a fresh one every 3 days.
Virus preparation and infection
Two HIV-1 strains with different modes of cell tropism
were used: NL432 as a T-tropic X4 virus (Adachi et al.,
1986) and JRFL as an M-tropic R5 virus (Koyanagi et al.,
1987). The wild-type and mutant viruses were prepared
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by transfection of 293T cells with the infectious proviral
HIV-1 clone by the calcium phosphate coprecipitation
method. The culture supernatants were collected and
clarified by centrifugation at 1500 g for 10 min and stored
at 80°C. Viruses, whose concentrations were adjusted
with respect to the amounts of p24 antigen, were used
for infection. Cells adherent to plastic culturewares were
infected with equal amounts of viruses for 2 h at 37°C,
washed with PBS() to remove unbound viruses, and
cultivated in the growth medium. PBLs in suspension
cultures were supplied with 100 U/ml recombinant hu-
man IL-2 (Life Technologies) 24 h before infection. The
PBLs were collected and infected with viruses for 16 h,
washed with PBS(), and cultured in the IL-2-containing
medium. One-half of the medium was replaced with a
fresh one every 3 days.
Immunoblot analysis
The culture medium containing HIV-1 was clarified by
centrifugation at 1500 g for 10 min, and then ultracentri-
fuged at 100,000 g for 1 h. Precipitated viruses were
lysed with the SDS–PAGE sample buffer. Viral proteins
were separated by 12% SDS–polyacrylamide gel electro-
phoresis and transferred to the PVDF membrane, fol-
lowed by immunoblotting using the anti-HIV-1 antibody at
a dilution of 1:100 (Bio-Rad: HIV NOVAPATH Immunoblot
assay: R-1 serum) or serum No357 from an HIV-1-in-
fected patient (Mochizuki et al., 1999).
Detection of virus infectivity
The amounts of p24 antigen in the culture superna-
tants of infected cells were measured using a p24 anti-
gen ELISA kit (Cellular Product Inc., Buffalo, NY). The
MAGI assay was carried out as described previously
(Kimpton and Emerman, 1992). Briefly, these cells were
infected with the virus for 2 h in the medium containing
20 g/ml DEAE-Dextran. Infected cells were cultured for
2 days, fixed with 1% formaldehyde–0.2% glutaraldehyde
in phosphate-buffered saline (PBS) for 5 min, washed,
and stained for 60 min at 37°C with the staining solution
[4 mM potassium ferrocyanide, 4 mM potassium ferri-
cyanide, 2 mM MgCl2, 0.4 mg/ml 5-bromo-4-chloro-3-
indolyl--D-galactoside (X-Gal)]. Blue foci in 96-well cul-
tures were counted automatically under a stereoscopic
microscope (Olympus SZX9) using an imaging system
software (Winroof; Mitani Corp., Tokyo). To evaluate the
virus-induced syncytium formation, infected macro-
phages were cultured for 18 days, fixed with 1% formal-
dehyde–0.2% glutaraldehyde, and visualized by Wright–
Giemsa staining (Sigma).
Detection of HIV-1 DNA by PCR
Before infection, viruses were treated with 200 U/ml
RNase-free DNase (Roche Molecular Biochemicals) for
1 h at 37°C. Infected cells were lysed with 200 l of 2 
PCR buffer [10 mM Tris–HCl (pH 8.3), 1% Nonidet P-40,
1% Tween 20] and mixed with an equal volume of 200
g/ml proteinase K (Roche Molecular Biochemicals) so-
lution. Proteins were digested overnight at 56°C and the
proteinase was inactivated for 10 min at 95°C. Different
dilutions of cell lysates were subjected to 25 cycles
(-tubulin primers) or 35 cycles (HIV-1-specific primers)
of PCR with rTaq polymerase (Toyobo Co., Ltd.). Each
cycle was composed of a denaturation step (94°C for
30 s), an annealing step (55°C for 30 s), and an extension
step (72°C for 1 min). The following primers described by
Schimidtmayerova et al. (1998) were synthesized and
used: for R/U5, 5-GGCTAACTAGGGAACCCACTG-3 and
5-CTGCTAGAGATTTTCCACACTGAC-3; for LTR/gag, the
first primer described above for R/U5 and 5-GCTTAAT-
ACCGATCTCGCA-3; for 2 LTR, 5-GCCTCAATAAAGCTT-
GCCTTG-3 and 5-TCCCAGGCTCAGATCTGGTCTAAC-
3; for -tubulins, 5-GTTGGTCTGGAATTCTGTCAG-3
and 5-AAGAAGTCCAAGCTGGAGTTC-3. PCR products
were separated by agarose gel electrophoresis and vi-
sualized by SYBR Green I nucleic acid gel staining (Mo-
lecular Probes, Inc., Eugene, OR).
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